$72.72
-1.23-1.66%
In chiusura: Sep 4, 5:00 PM EST
$72.72
N/A
Post-mercato: 4:00 PM EST
Cytokinetics Inc
CYTKNASDAQ
Cytokinetics Earnings & Forecasts
Cytokinetics (CYTK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Cytokinetics Guidance
Cytokinetics (CYTK) ha pubblicato l'ultima guidance il febbraio 27, 2024 per fiscal year 2024. La società ha previsto un fatturato pari a $3M - $5M per il periodo.
Rispetto alle previsioni precedenti, Cytokinetics {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
Cytokinetics ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Cytokinetics. 2
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.62 | $-1.65 | $-1.41 | $-1.58 |
| Actual | $-1.50 | $-1.67 | $-1.50 | $-1.54 |
| Surprise | +7.41% | -1.21% | -6.38% | +2.53% |
| Revenue | ||||
| Estimate | $17.2M | $8.5M | $6.4M | $5.9M |
| Actual | $28.6M | $19.4M | $17.8M | $1.9M |
| Surprise | +66.0% | +128.1% | +178.7% | -66.9% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.45 | $-1.43 | $-1.46 | $-1.33 |
| Revenue | ||||
| Consensus | $40.2M | $59.8M | — | — |